RxDoctor Payments Data

Daniel Swanson, MD

Urology · Billings, MTNPI 1447575154

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,491 of the $2,238 with a category attached, or 66.6%. 18 manufacturers reported payments, led by Neotract Inc. at 33.4% of the total. Reporting peaked in 2019 at $850 and has fallen 71.9% since, to $239 in 2025.

$2,238in general payments, 2019–2025

Across 34 payments — averaging $65.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neotract Inc.$748
  • Axonics, Inc.$287
  • Olympus America Inc.$170
  • Urogen Pharma, Inc.$150
  • AbbVie$147
  • Sumitomo Pharma America, Inc.$143
  • plus $594 from 12 others

What the payments were for

  • Travel & lodging$73933%
  • Food & beverage$1,49167%
  • Education$80%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,238 in reported general payments places this provider in the 60th percentile of 45 urology providers in Montana.

See all urology providers in Montana

Medicare billing

Part B allowed, 2024
$140,415
Medicare patients
450
Services billed
1,272

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron73$39,414
Tamsulosin Hcl319$3,361
Solifenacin Succinate92$1,689
Methenamine Hippurate26$1,454
Finasteride133$1,128
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst49$1,046
Testosterone Cypionate13$635
Potassium Citrate ErPotassium Citrate11$502
Alfuzosin Hcl ErAlfuzosin Hcl33$295
Oxybutynin Chloride29$179
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim15$80
Oxybutynin Chloride ErOxybutynin Chloride13$69
Ciprofloxacin Hcl16$65
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen16$51

Paid to pharmacies, not to this prescriber.

Other urology in Billings

See the full list for Montana

Where these figures come from

Is this you, or does something look wrong? →